Skip to main content

I am co-head of Fieldfisher's International Life Sciences and healthcare group. I am a transactional lawyer advising on both corporate and IP deals. On the corporate side these including venture investment, joint ventures, pharma asset divestment and in particular cross-border structured M&A deals. In the transactional intellectual property field deals include structured licensing, strategic partnering, co-operative research and development and drug supply.
 
I'm passionate about the life sciences sector and have an D.Phil. in Biochemistry from the University of Oxford.
 
I am a fellow of the Royal Society of Medicine and a fellow of the Royal Society of Biology and sit on a number of advisory committees of the BIA.

Prior to joining Fieldfisher, I spent 14 years at another international law firm, where I was head of their UK life science and healthcare group.
 

Recent notable transactions that I have advised on include:
 
  • Phynova on its €10 million funding round by DSM Venturing, part of Royal DSM.
  • ​MedAnnex on £11.5M Morningside ventures investment.
  • Intelligent Ultrasound on first OEM partner agreement for its AI based imaging software.
  • Garrison (cyber security company) on £22.9m funding round.
  • Sensyne Health in connection with its AIM IPO.
  • Cancer Rop on $10M investment into cancer vaccine firm, Oxford Vacmedix.
  • Biotecnol on Cancer Research UK partnership to trial new immunotherapy.
  • Actavis UK and Actavis Ireland in relation to its £603m divestment by Teva to Intas.
  • Invicro on acquisition of Imanova.
  • StarLeaf on $40m Series B fundraising.
  • Accelovance Inc on its multimarket agreement to acquire THERAMetrics CRO operations.
  • Acano on its $700m acquisition by Cisco.


 

Download Profile

Download Now